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The 63rd annual Montagna Symposium
on the Biology of Skin, ‘‘Skin Aging:
Molecular Mechanisms and Tissue Con-
sequences,’’ was held from 9–13 Octo-
ber 2014, in Gleneden Beach, Oregon.
The meeting brought together basic
gerontologists, dermatologists, and skin
biologists working on mechanisms and
problems of skin aging, industry scien-
tists attempting to create products to
address unmet needs in the field, and
trainees wishing to acquire a better
understanding of the aging process and
its consequences in the skin. The many
recent advances in both basic and
applied aspects of cutaneous aging led
to productive exchanges among these
participants, broadened everyone’s hor-
izons, and stimulated several new col-
laborations. The Symposium was
chaired by Barbara A. Gilchrest with
Session Chairs Judith Campisi, Howard
Chang, and Gary Fisher.
The meeting opened with a Keynote
presentation by Jan Vijg. Dr Vijg began
by pointing out the great progress that
has been made over the last two cen-
turies in increasing both life expectancy
and health span––i.e., the average time
span an individual can expect to remain
functional. However, further progress
depends entirely on gaining a deeper
understanding of the intrinsic mechan-
isms that underlie the aging process and
predisposition to disease. Among the
many theories of how we age, one of
the oldest is based on the accumulation
of errors in genome and epigenome.
Although conceptually fairly simple, this
theory proved extremely difficult to test
because mutations and epimutations
occur at low frequency, turning each
tissue into genome mosaics. Dr Vijg
presented data from his group on their
single-cell approach to the study of
somatic DNA mutations and epimuta-
tions in aging tissues. Making use of the
most recent next-generation sequencing
methods, their data indicated that the
frequency of somatic mutations is much
higher than previously thought, with
many mutations inactivating gene func-
tion. Dr Vijg discussed these results in
the context of some broader philosophi-
cal and ethical questions posed by the
study of aging. For example, in view of a
gradual erosion of genome and epigen-
ome integrity, is it feasible to develop
interventions to delay, halt, or even
revert aging, and are there ethical costs?
This discussion provided participants
with an engaging, big-picture introduc-
tion to the meeting’s theme.
Session Chair Howard Chang drew
the connection between aging and stu-
dies of epigenetics—the mechanisms of
gene memory over time—and then
introduced recent findings that the
human genome encodes thousands of
long noncoding RNAs, many of which
have functions in chromatin regulation.
Chang reported that the stress-respon-
sive transcription factor NF-kB is
increasingly active with age in the skin
and other tissues and that interruption of
NF-kB activity in aged skin can restore
many features of young skin. He
then described long noncoding RNAs
that are regulated by NF-kB, focusing on
Lethe, which is induced by NF-kB and
in turn dampens the NF-kB response,
helping cells forget that they were
stressed in the past. Chang concluded
by describing a new technology that can
map chromatin changes in just a few
thousand cells, finding that many age-
associated changes are only evident in
the long-lived stem cell compartment of
tissue.
Ruby Ghadially discussed functional
studies of human epithelial stem cells.
Although human skin stem cells can be
enriched by one or more cell surface
markers, their functional characteriza-
tion had previously depended on
in vitro colony-forming assays. Dr Gha-
dially showed that intradermal injection
of skin stem cells can recapitulate some
aspects of wound healing and lead to
the formation of epidermal inclusion
cysts where cells undergo keratiniza-
tion. This assay system also allowed
comparison of the proliferative capacity
of epithelial stem cells in vivo, albeit in
a xenograft setting, and can be used to
compare stem cells in different settings,
including aging.
If seeing is believing, Valentina Greco
continued the session with an exciting
presentation on in vivo imaging of stem
cell niche. Dr Greco developed cutting-
edge two-photon microscopy methods
and transgenic animals with fluorescent
nuclei in skin cells in order to make
movies of how individual cells in
hair follicles move and develop.
Direct visualization of cell dynamics
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overturned several dogmas in the skin
stem cell field, including the idea that
stem cells are somehow uniquely speci-
fied. In fact, if existing hair follicle stem
cells are destroyed, other cells can take
their place, influenced by the unique
environment of the niche. During hair
follicle regression in catagen, Dr Greco
showed that only the outer root sheath
cells die, whereas the inner root sheath
cells move up the follicle. The signal for
outer root sheath cells to die emanates
from mesenchymal cells in the dermal
papilla. These results raised the concept
that the mesenchymal cells in the der-
mal papilla may be the intrinsic clock
for hair follicle cycling over time.
Ray Monnat followed with studies of
the Werner Syndrome, a disease with
many features of premature aging aris-
ing from loss of function mutations in
the WRN helicase gene. A consequence
of this progeroid syndrome is the
increased incidence of cancers, includ-
ing melanoma, with an over 50-fold
increase in Werner Syndrome patients.
Dr Monnat identified several aspects of
DNA metabolism that are altered in
Werner Syndrome cells. He found that
the rate of the DNA replication fork
progression is altered, and many genes
exhibit altered expression levels. The
changes in gene expression apparently
had large effects on genes encoding
tRNA synthetase pathways; thus, unex-
pectedly, a defect in DNA metabolism
or replication may indirectly impact
protein translation.
Danica Chen concluded the session
with a presentation on aging and sir-
tuins. Although sirtuins were first recog-
nized for their roles in chromatin
regulation in the nucleus, Chen reported
the novel roles of the mitochondrial
resident Sirt3 protein in aging. She
showed that Sirt3 is important to deace-
tylate superoxide dismutase 2, a key
enzyme to detoxify reactive oxygen
species, and that Sirt3 is necessary to
prevent the build-up of reactive oxygen
species in aged hematopoietic stem
cells. Another sirtuin, Sirt7, responds to
stress signals in the endoplasmic reticu-
lum and signals the translational
machinery to slow down accordingly.
Sirt7-deficient animals exhibit fatty liver
and altered hematopoietic stem cell
function, which can be reversed by
pharmacologic alleviation of endoplas-
mic reticulum stress.
Session Chair Judith Campisi intro-
duced the multifaceted stress response
termed cellular senescence. Senescent
cells are characterized by an essentially
irreversible arrest of cell proliferation
and a complex senescence-associated
secretory phenotype composed of
numerous growth factors, inflammatory
cytokines, and proteases. The senes-
cence growth arrest is known to be an
important tumor suppressive mechan-
ism. The senescence-associated secre-
tory phenotype, however, is a double-
edged sword. Using a mouse model that
allows the visualization, sorting, and
selective elimination of senescent cells,
Campisi presented evidence that skin
wounding is accompanied by a rapid
but transient appearance of senescent
cells, primarily fibroblasts and endothe-
lial cells that secreted platelet-derived
growth factor AA, a newly identified
senescence-associated secretory pheno-
type factor that was essential for optimal
wound closure. By contrast, the chronic
presence of senescent cells, which can
occur in response to whole-body radia-
tion, systemic genotoxic chemotherapy,
or oxidative stress, is deleterious and
can promote tumor metastasis and
retard skin wound healing.
Anne Chang followed with a presen-
tation on the marked individual varia-
tion in the ability to maintain skin
youthfulness during aging, a phenotype
that thus far has been poorly character-
ized. At least some of the ability to
maintain healthy, youthful-appearing
skin into advanced age appears to have
a genetic basis. Chang suggested that a
shift in focus from skin aging to skin
youthfulness can uncover new key
pathways that regulate skin health
and potential interventions to restore
skin youthfulness pathways in aged
individuals.
Barbara A. Gilchrest discussed the
promise of T-oligos, oligonucleotides
that are homologous to the vertebrate
telomere DNA repeat sequence
(TTAGGG). Human telomeres shorten
progressively with repeated cell division
owing to the biochemistry of DNA
replication and because most human
cells only minimally express telomerase,
the enzyme that adds telomeric
sequences de novo. Long-term exposure
to T-oligos mimics the effects of short,
dysfunctional telomeres, but short-term
exposure to T-oligos elevates DNA
repair capacity, increases telomerase
activity, and elongates telomeres. These
studies indicate another doubled-edged
sword. At low levels, DNA damage
signaling, such as that caused by short-
term T-oligo exposure, is protective,
increasing DNA repair systems, telomer-
ase expression, and telomere length. At
higher levels, such as that caused by
long-term T-oligo and excessive sun
exposures, the protective effects are over-
whelmed and DNA damage signaling
then drives apoptosis and senescence.
Steven Artandi closed the session by
elucidating how telomerase expression
and assembly are controlled. In both
mice and humans, the identification
of telomerase-positive cells has been
elusive owing to the very low expression
of the holoenzyme components. The
Artandi laboratory recently overcame
this limitation by generating a knock-in
reporter mouse model in which the
open reading frame of TERT, the reverse
transcriptase subunit of the enzyme, is
replaced by fluorescent proteins, allow-
ing tracking of telomerase-positive stem
and transit amplifying cells and deter-
mining their role in telomere length
maintenance. New evidence suggests
that telomerase is assembled in sub-
nuclear domains such as Cajal bodies,
an important step in the optimal expres-
sion and localization of the enzyme.
These findings promise deeper insights
into telomerase regulation during carci-
nogenesis and natural aging.
Session Chair Gary Fisher presented
three-dimensional videos of second har-
monic generation signals and atomic
force microscopy nanoscale images that
illustrated deterioration of collagen
fibrils with aging. Multiphoton fluores-
cence microscopy images further
revealed that attachment of fibroblasts
to collagen fibrils is disrupted by frag-
mentation, leading to reduced fibroblast
spreading. Fibroblasts respond to loss of
attachment by upregulating production
of collagen-degrading matrix metallo-
proteinases and downregulating produc-
tion of collagen, leading to further
collagen deficit, with attendant decline
of skin health. Human intervention
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studies demonstrated that fibroblasts
in aged skin could be ‘‘rejuvenated’’
by enhancing structural support and
mechanical force within the dermis, by
injection of cross-linked hyaluronic acid
(HA) dermal filler. Thus, functional
decline of dermal fibroblasts may be
largely a reflection of their tissue envir-
onment and not irreversible.
The theme of the reversibility of some
features of skin aging was further
advanced by Sewon Kang, who pre-
sented an overview of retinoids and
their ability to improve the appearance
of aged human skin. Although the
mechanisms by which retinoids improve
appearance are not precisely known,
the induction of collagen appears to be
a critical factor. Retinoic acid stimulated
production of type VII collagen anchor-
ing fibrils and type I collagen. Retinoid
dermatitis, a side effect due to the
actions of retinoids on the epidermis,
could be partially mitigated by combina-
tion with inhibitors of EGFR, potentially
improving tolerability and therapeutic
benefit.
Vera Gorbunova presented fascinat-
ing connections between longevity,
essentially complete resistance to all
types of cancers, and the unique proper-
ties of hyaluronic acid, a long chain
polysaccharide composed of repeating
units of the D-glucuronic acid and
N-acetylglucosamine, in the naked mole
rat. This mammal has a life expectancy
exceeding 30 years. High viscosity of
culture media from naked mole rat
fibroblasts was traced to secretion of
large amounts of very long chains
(molecular weights 6–12 times greater
than in mice or humans) of HA.
Increased length of HA chains was
found to be due to two amino acid
substitutions within the active site of
the major HA-synthesizing enzyme
HAS2. Both increased expression of
HAS2 and reduced expression of HA-
degrading activities were found to be
responsible for high HA content in the
naked mole rat. Interestingly, inhibition
of high molecular weight HA produc-
tion conferred oncogenic transformation
on normally resistant naked mole rat
fibroblasts. These data reveal that long
chain HA has unique anti-cancer
properties; however, the precise mech-
anism of this activity remains to be
determined. We eagerly await the
results of ongoing studies to determine
whether transgenic expression of naked
mole rat HAS2 will extend the life span
of mice.
Yong Li presented the role of prosta-
glandins in loss of skin collagen during
aging, a novel counterpart to the activity
of these well-known lipid mediators of
immunity and inflammation in the skin.
cDNA microarray analysis of the skin
from persons of varying ages revealed
that the gene responsible for prostaglan-
din E2 synthesis, PTGES1, strongly posi-
tively correlated with age. Compelling
data showed that PTGES1 expression is
highly sensitive to fibroblast spreading.
The potential for clinical translation of
these findings is high. Nonsteroidal
anti-inflammatory drugs, which are
well-known to inhibit prostaglandin E2
production, provided proof of concept,
with one such drug raising collagen
levels in aged human skin.
Richard Clark described his recent
studies on fibronectin-derived peptide
P12. Fibronectin provides a substrate
for dermal cell attachment, migration,
and growth during wound healing. P12
peptide displays strong binding to plate-
let-derived growth factor BB, and this
binding enhances its growth promoting
activity. Aged pre-senescent fibroblasts
lack sufficient traction force to expose
P12 and therefore respond poorly to
platelet-derived growth factor BB.
Responsiveness to platelet-derived
growth factor BB could be markedly
improved by addition of exogenous
P12. This raises the intriguing possibility
that P12 may be therapeutic to improve
wound healing in the elderly.
Vincent Monnier wrapped up the
session by discussing glycation of extra-
cellular matrix molecules, such as
collagen and elastin, resulting in accu-
mulation of advanced glycation end
products during aging. This accumula-
tion alters the structure and mechanical
properties of dermal collagen and elas-
tin, deleterious to both the physical
properties and functions of dermal cells.
Unfortunately, to date, strategies to
remove advanced glycation end pro-
ducts in vivo have been unsuccessful;
however, understanding of the chemis-
try of glycation has led to identifica-
tion of several molecules that retard
glycation formation. Thus, using such
agents to extend skin health during
aging remains a possibility.
To open Barbara A. Gilchrest’s ses-
sion, Vladimir Botchkarev discussed
epigenetic regulation of skin stem cell
activity in skin development, aging, and
cancer. Specifically, his group looked at
how p63 and epigenetic regulators
interact to promote, establish, and main-
tain epidermal differentiation program
in keratinocytes and how these
epigenetic mechanisms provide novel
approaches for the treatment of age-
associated skin disorders.
Calvin B. Harley outlined methods for
measuring telomerase activity and telo-
mere length and the potential of these
methods and measurements to improve
clinical practice in dermatology and
beyond. Beginning with an overview of
telomere biology, Dr Harley went on to
present telomere measurement techni-
ques such as quantitative reverse trans-
criptase in real time and quantitative
fluorescent in situ hybridization and
their applications in cancer care and
the wellness market, as well as a poten-
tial role for these methodologies in such
areas as improved skin biopsies and
telomere vaccines.
J. Silvio Gutkind presented his group’s
multi-institutional clinical trial exploring
the anti-tumor effects of rapamycin on
newly diagnosed head and neck squa-
mous cell carcinoma, which also
yielded data about the role of mTOR
in skin aging, specifically, that the inhi-
bition of mTOR may prevent premature
aging of the skin without increasing
cancer incidence.
Maria Eriksson presented her group’s
work on the Hutchinson-Gilford pro-
geria syndrome (HGPS) as a model for
normal aging, including recent studies
on the expression of HGPS mutation in
basal cells of the interfollicular epider-
mis resulting in the upregulation of
lamin B receptor in the suprabasal cell
layer, and on the development of trans-
genic mouse models with expression of
this mutation only in certain cell types,
shedding light on systemic responses
underlying aging phenotypes.
Dr Eriksson’s talk was followed by
three short talks. Rosemarie Osborne
described her group’s efforts to define
molecular pathways involved in
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intrinsic skin aging and photoaging,
using transcriptional profiling tools that
elucidate the expression of genes asso-
ciated with changes in cellular energy
production. Abbas Raza presented his
lab’s current work on acyclothymidine
dinucleosides as structural mimetics of
DNA, with data showing that topical
application of acyclothymidine dinu-
cleosides resulted in DNA photoprotec-
tion in both mouse and human skin
exposed to UVB. Abdoelwaheb el
Ghalbzouri described his group’s work
on reticular and papillary fibroblasts in
human skin equivalents.
The meeting’s final session began
with five short talks on current trends
in industry research. Raaj Khusial pre-
sented work on a novel role for autop-
hagy in epidermal differentiation.
Michael Milane outlined a phase 2
clinical study evaluating the safety and
efficacy of aminolevulinic acid photo-
dynamic therapy for reducing the inci-
dence of facial actinic keratoses in high-
risk patients. Florence Nadal-Wollbold
presented data from an industry-
academic collaboration on the role of
carbonyl stress in actinic elastosis and
photoaging. Tracy Shafizadeh gave an
overview of the metabolome and how it
may be useful in the development of
therapeutics and skin care products.
Betty Yu presented data showing a plat-
form that employs topically applied
invisible cross-linked polymer films to
enhance hydration, provide support,
and otherwise improve compromised
skin.
Barbara A. Gilchrest and Sewon Kang
moderated the culminating Future
Directions panel. Panelists Chris de
Bryune, John Doux, and Serge Lichtstei-
ner led a discussion on current
approaches and opportunities/barriers
to new dermatologic products, drugs,
and cosmeceuticals and implications for
translation from bench to bedside. This
lively and candid exchange aired
experiences, shared perspectives of
obstacles, and set forth new mechan-
isms for synergy between industry, aca-
demia, and government researchers,
bringing the meeting to a noteworthy
conclusion.
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